Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension

Clinical trial NCT02145611 · COMPLETED

Trial details

NCT number: NCT02145611
Sponsor: Dr. José Fernando Vilela-Martin MD PhD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Hypertension Endothelial Dysfunction

Start date: 2013-07-01
Primary completion: 2016-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.